Ikarian Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,640
| Closed | -$374K | – | 120 |
|
|
2022
Q1 | $374K | Buy |
9,640
+602
| +7% | +$23.4K | 0.05% | 109 |
|
|
2021
Q4 | $528K | Buy |
+9,038
| New | +$528K | 0.08% | 95 |
|
|
2021
Q3 | – | Sell |
-3,600
| Closed | -$313K | – | 167 |
|
|
2021
Q2 | $313K | Hold |
3,600
| – | – | 0.03% | 143 |
|
|
2021
Q1 | $297K | Buy |
+3,600
| New | +$297K | 0.01% | 156 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 160 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 123 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 102 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 93 |
|